Literature DB >> 11236944

Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches--functional and prognostic information.

P F Ambros1, G Méhes, C Hattinger, I M Ambros, A Luegmayr, R Ladenstein, H Gadner.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11236944     DOI： 10.1038/sj.leu.2402023

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Feasibility of a cost-effective approach to evaluate short tandem repeat markers suitable for chimerism follow-up.

Authors:  Ariela F Fundia; Carlos De Brasi; Irene Larripa
Journal:  Mol Diagn       Date:  2004

2.  Circulating breast cancer cells are frequently apoptotic.

Authors:  G Méhes; A Witt; E Kubista; P F Ambros
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Detection of disseminated tumor cells in neuroblastoma: 3 log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytology.

Authors:  Gabor Méhes; Andrea Luegmayr; Rosa Kornmüller; Ingeborg M Ambros; Ruth Ladenstein; Helmut Gadner; Peter F Ambros
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

4.  Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.

Authors:  M Reza Abbasi; Fikret Rifatbegovic; Clemens Brunner; Georg Mann; Andrea Ziegler; Ulrike Pötschger; Roman Crazzolara; Marek Ussowicz; Martin Benesch; Georg Ebetsberger-Dachs; Godfrey C F Chan; Neil Jones; Ruth Ladenstein; Inge M Ambros; Peter F Ambros
Journal:  Clin Cancer Res       Date:  2017-02-22       Impact factor: 12.531

5.  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Authors:  P F Ambros; I M Ambros; G M Brodeur; M Haber; J Khan; A Nakagawara; G Schleiermacher; F Speleman; R Spitz; W B London; S L Cohn; A D J Pearson; J M Maris
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.